Halozyme prices $1.3B convertible notes due 2033
Halozyme priced $1.3 billion of 1.50% convertible senior notes due 2033 and granted a 13-day option to sell up to $200 million more.
Key Highlights:Original SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - 8-K - Sep. 18, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider verifyin…